Company · CIK 1956827

# Abivax S.A.

| CIK | [1956827](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001956827) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | I0 |
| Listed | ABVX (Nasdaq), AAVXF (OTC) |
| First annual or quarterly report | 2024-04-05 |

## Offerings

 2 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-283336 | Shelf Effective | 2024-11-19 | 2024-11-26 | 2 |
| 333-274780 | IPO Final prospectus | 2023-09-29 | 2023-10-23 | 5 |

## Filings

 13

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-07-02 | [424B5](https://www.sec.gov/Archives/edgar/data/1956827/000119312526294491/0001193125-26-294491-index.htm) Shelf takedown | 333-288884 | 0001193125-26-294491 |
| 2026-06-30 | [424B5](https://www.sec.gov/Archives/edgar/data/1956827/000119312526290817/0001193125-26-290817-index.htm) Shelf takedown | 333-288884 | 0001193125-26-290817 |
| 2025-07-24 | [424B5](https://www.sec.gov/Archives/edgar/data/1956827/000119312525164456/0001193125-25-164456-index.htm) Shelf takedown | 333-288884 | 0001193125-25-164456 |
| 2025-07-23 | [424B5](https://www.sec.gov/Archives/edgar/data/1956827/000119312525163478/0001193125-25-163478-index.htm) Shelf takedown | 333-288884 | 0001193125-25-163478 |
| 2024-11-26 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1956827/999999999524003594/9999999995-24-003594-index.htm) Declared effective | 333-283336 | 9999999995-24-003594 |
| 2024-11-19 | [F-3](https://www.sec.gov/Archives/edgar/data/1956827/000119312524261713/0001193125-24-261713-index.htm) Shelf registered | 333-283336 | 0001193125-24-261713 |
| 2023-10-23 | [424B4](https://www.sec.gov/Archives/edgar/data/1956827/000119312523260833/0001193125-23-260833-index.htm) Final prospectus | 333-274780 | 0001193125-23-260833 |
| 2023-10-19 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1956827/999999999523003017/9999999995-23-003017-index.htm) Declared effective | 333-274845 | 9999999995-23-003017 |
| 2023-10-19 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1956827/999999999523003016/9999999995-23-003016-index.htm) Declared effective | 333-274780 | 9999999995-23-003016 |
| 2023-10-18 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1956827/000119312523258642/0001193125-23-258642-index.htm) Amendment | 333-274780 | 0001193125-23-258642 |
| 2023-10-16 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1956827/000119312523256667/0001193125-23-256667-index.htm) Amendment | 333-274780 | 0001193125-23-256667 |
| 2023-09-29 | [F-1](https://www.sec.gov/Archives/edgar/data/1956827/000119312523247378/0001193125-23-247378-index.htm) Registration filed | 333-274780 | 0001193125-23-247378 |
| 2022-12-16 | [DRS](https://www.sec.gov/Archives/edgar/data/1956827/000095012322012666/0000950123-22-012666-index.htm) Draft made public | 377-06511 | 0000950123-22-012666 |

[All filings of this company](https://equitycapital.markets/filings?cik=1956827) · [CSV](https://equitycapital.markets/filings.csv?cik=1956827)

---
Source page: https://equitycapital.markets/company/1956827 · Data: U.S. SEC EDGAR · CC BY 4.0